ArticleMicroorganisms2022

Identifying Different Mutation Sites Leading to Resistance to the Direct-Acting Antiviral (DAA) Sofosbuvir in Hepatitis C Virus Patients from Egypt.

Aly Atef Shoun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.